Chiba University
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1949-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.chiba-u.ac.jp
Clinical Trials
288
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (288 trials with phase data)• Click on a phase to view related trials
Cities for Better Health Childhood Obesity Prevention Initiative in JAPAN
- Conditions
- Quality of Life (QOL)NutritionObesityChildhood ObesityPhysical Activity
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 2200
- Registration Number
- NCT07061665
- Locations
- 🇯🇵
Chiba University, Chiba, Japan
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
- Conditions
- ANCA Associated Vasculitis (AAV)
- Interventions
- Drug: Avacopan, prednisolone and rituximab
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 160
- Registration Number
- NCT06611696
- Locations
- 🇯🇵
Fujita Health University Hospital, Toyoake, Aichi, Japan
🇯🇵Asahi General Hospital, Asahi, Chiba, Japan
🇯🇵Chiba Rosai Hospital, Ichihara, Chiba, Japan
Open-label Clinical Trial of Lacosamide in ALS
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 7
- Registration Number
- NCT03186040
- Locations
- 🇯🇵
Chiba University Hospital, Chiba, Japan
Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 211
- Registration Number
- NCT02770794
- Locations
- 🇯🇵
Chiba University Hospital, Chiba, Japan
JET-GBS - Japanese Eculizumab Trial for GBS
- First Posted Date
- 2015-07-09
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- Chiba University
- Target Recruit Count
- 34
- Registration Number
- NCT02493725
- Locations
- 🇯🇵
Nagoya University Hospital, Nagoya, Aichi, Japan
🇯🇵Hokkaido University Hospital, Sapporo, Hokkaido, Japan
🇯🇵Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
- Prev
- 1
- 2
- 3
- 4
- Next
News
First Clinical Trial Shows Nicotinamide Riboside Improves Multiple Health Outcomes in Werner Syndrome Patients
Japanese researchers conducted the world's first rigorous clinical trial of nicotinamide riboside (NR) in Werner syndrome patients, showing significant improvements in cardiovascular health, skin ulcers, and kidney function.